当前位置:首页 - 行情中心 - 雪榕生物(300511) - 财务分析 - 现金流量表

雪榕生物

(300511)

  

流通市值:41.39亿  总市值:48.58亿
流通股本:5.46亿   总股本:6.41亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金676,114,712.661,962,574,102.431,315,813,490.16782,645,435.41
  收到的税费返还---1,577.59
  收到其他与经营活动有关的现金15,105,000.7119,836,012.6132,947,291.3230,992,888.16
  经营活动现金流入小计691,219,713.371,982,410,115.041,348,760,781.48813,639,901.16
  购买商品、接受劳务支付的现金347,816,267.141,069,149,863.24701,172,110.14424,957,192.19
  支付给职工以及为职工支付的现金115,258,867.38408,888,878.2335,894,388.41212,788,917.34
  支付的各项税费5,838,883.8724,753,180.115,733,133.0310,138,502.16
  支付其他与经营活动有关的现金18,704,229.3463,770,066.8547,804,206.2227,455,080.12
  经营活动现金流出小计487,618,247.731,566,561,988.391,100,603,837.8675,339,691.81
  经营活动产生的现金流量净额203,601,465.64415,848,126.65248,156,943.68138,300,209.35
二、投资活动产生的现金流量:
  收回投资收到的现金-4,600,0004,600,0004,600,000
  处置固定资产、无形资产和其他长期资产收回的现金净额654,697.3425,588,465.4811,887,467.8811,720,097.18
  投资活动现金流入小计654,697.3430,188,465.4816,487,467.8816,320,097.18
  购建固定资产、无形资产和其他长期资产支付的现金72,568,778.6779,587,860.5559,319,655.1626,453,407.12
  投资活动现金流出小计72,568,778.6779,587,860.5559,319,655.1626,453,407.12
  投资活动产生的现金流量净额-71,914,081.33-49,399,395.07-42,832,187.28-10,133,309.94
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,000,000700,000700,000-
  其中:子公司吸收少数股东投资收到的现金1,000,000700,000700,000-
  取得借款收到的现金160,050,000453,813,392.08320,440,000193,590,000
  收到其他与筹资活动有关的现金-102,485,991.1102,000,000102,000,000
  筹资活动现金流入小计161,050,000556,999,383.18423,140,000295,590,000
  偿还债务支付的现金114,004,274.12779,469,044.75588,648,252.9433,582,190.54
  分配股利、利润或偿付利息支付的现金7,929,749.4142,678,550.247,098,835.0532,598,884.9
  支付其他与筹资活动有关的现金42,199,866.6792,362,201.6537,730,064.3731,234,364.37
  筹资活动现金流出小计164,133,890.2914,509,796.6673,477,152.32497,415,439.81
  筹资活动产生的现金流量净额-3,083,890.2-357,510,413.42-250,337,152.32-201,825,439.81
四、汇率变动对现金及现金等价物的影响-1,074,410.07259,737.3739,063.65129,262.32
五、现金及现金等价物净增加额127,529,084.049,198,055.53-44,973,332.27-73,529,278.08
  加:期初现金及现金等价物余额159,139,572.15149,941,516.62149,941,516.62149,941,516.62
  期末现金及现金等价物余额286,668,656.19159,139,572.15104,968,184.3576,412,238.54
补充资料:
  净利润-38,418,736.45--97,273,595.86
  资产减值准备-16,982,953.22--617,599.52
  固定资产和投资性房地产折旧-327,920,341.21-169,902,123.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-327,920,341.21-169,902,123.38
  无形资产摊销-8,710,482.78-3,948,172.77
  长期待摊费用摊销-2,902,819.36-1,532,985.83
  处置固定资产、无形资产和其他长期资产的损失--16,311,304.25-12,375,039.33
  固定资产报废损失-1,227,784.72-449,324.37
  公允价值变动损失--38,348.96--
  财务费用-60,605,468.47-35,326,614.88
  投资损失--1,013,061.49--1,013,061.49
  存货的减少--61,423,165.92--16,885,419
  经营性应收项目的减少--18,155,174.09-1,755,107
  经营性应付项目的增加-55,008,100.98-49,569,951.35
  其他----21,303,171.01
  债务转为资本-642,982,858.51--
  现金的期末余额-159,139,572.15-76,412,238.54
  减:现金的期初余额-149,941,516.62-149,941,516.62
  现金及现金等价物的净增加额-9,198,055.53--73,529,278.08
公告日期2026-04-282026-04-282025-10-162025-08-27
审计意见(境内)标准无保留意见
TOP↑